Barron's

Magazine

Here Comes the Next Wave of GLP-1s. They’ll Treat a Lot More Than Obesity.

Here Comes the Next Wave of GLP-1s. They’ll Treat a Lot More Than Obesity.

This blockbuster class of drugs is shattering all sales records. Which stock will do better—Eli Lilly or Novo Nordisk?

Reddit Is Due for Big AI Bump. The Earnings Selloff Is a Buying Opportunity.

Reddit Is Due for Big AI Bump. The Earnings Selloff Is a Buying Opportunity.

Reddit has become the voice of the internet. Why the future of AI could depend on the company’s success.

Long Read

Publicis Is Winning the AI Advertising Race, and Its Stock Still Looks Cheap

Publicis Is Winning the AI Advertising Race, and Its Stock Still Looks Cheap

Publicis is pairing AI-powered marketing with strong client retention, growing free cash flow, and a major data acquisition. Despite outperforming peers, the shares still trade at a discount.

Long Read

The Road to AI Trading Began Here

The Road to AI Trading Began Here

Ticker tapes and green-glowing Quotron computers reshaped Wall Street as the cutting-edge technologies of their day. Now comes the age of artificial intelligence.

Long Read

A Tired Tech Trade Looks Set to Sink the Stock Market

A Tired Tech Trade Looks Set to Sink the Stock Market

The stock market is doubting everything it once held true, and it has the potential to end the years of easy returns.

Long Read


Want to Be a Millionaire? Don’t Start a Business. Run for Congress.

The U.S. needs legislation to stop members of Congress from getting rich over the course of decades in office, Brian Hamilton writes.

4 minute read

This Value Investor Favors Global Stocks With Low Valuations, Dividends

Rupal Bhansali, CEO of Double Duty Money Management, finds bargains in France, Denmark, and Brazil. Why she likes UPS.

Long Read

Columns

Departments